American Society of Clinical Oncology

SHERPA: White

People

  1. Maki
    Maki
  2. Antonescu
    Antonescu
  3. Keohan
    Keohan
  4. Hensley
    Hensley
  5. Kelsen
    Kelsen
  6. Kurtz
    Kurtz
  7. Lefkowitz
    Lefkowitz
  8. Ludwig
    Ludwig
  9. O'Reilly
    O'Reilly
  10. Qin
    Qin

Groups

  1. GSK Faculty (5)
  2. Tow Center for Developmental Oncology (TCDO) (5)
  3. Department of Medicine (4)
  4. Solid Tumor Oncology Division (4)
  5. Sarcoma Service (3)
  6. Biostatistics Service (1)
  7. Body Imaging Service (1)
  8. Center for Pancreatic Cancer Research (1)
  9. Clinical Genetics Service (1)
  10. Division of Subspecialty Medicine (1)
Search Within
  1. "2011"
  2. "David D'Adamo"
Formats
  1. Meeting Abstract (6)
Groups
  1. GSK Faculty (5)
  2. Tow Center for Developmental Oncology (TCDO) (5)
  3. Department of Medicine (4)
  4. Solid Tumor Oncology Division (4)
  5. Sarcoma Service (3)
  6. Biostatistics Service (1)

More Groups

People
  1. David D'Adamo (6)
  2. Cristina Antonescu (5)
  3. Robert Maki (5)
  4. Mary Keohan (3)
  5. Angela Cioffi (2)
  6. Antoine Italiano (2)

More People

Years
  1. 2011 (6)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): Final results of a University of Chicago Phase II Consortium trial
    Meeting Abstract

    Kindler, H. L.; Campbell, N. P.; Wroblewski, K.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Gandara, D. R.; Antonescu, C.; Stadler, W. M.; Vokes, E. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Patterns of care, prognosis, and survival of patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib
    Meeting Abstract

    Italiano, A.; Cioffi, A.; Maki, R. G.; Schoffski, P.; Rutkowski, P.; Le Cesne, A.; Duffaud, F.; Adenis, A.; Isambert, N.; Bompas, E.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Metastatic epitheloid hemangioendothelioma (EHE): Role of systemic therapy and survival
    Meeting Abstract

    Cioffi, A.; Italiano, A.; Penel, N.; Berge, Y.; Toulmonde, M.; Salas, S.; Chevreau, C.; Le Cesne, A.; Duffaud, F.; D'Adamo, D. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation
    Meeting Abstract

    Lowery, M. A.; Stadler, Z. K.; Ludwig, E.; Salo-Mullen, E.; D'Adamo, D. R.; Allen, P. J.; Kurtz, R. C.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Campbell, N. P.; Wroblewski, K.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Gandara, D. R.; Antonescu, C.; Stadler, W. M.; Vokes, E. E.; Kindler, H. L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save